Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$50.47 - $66.26 $231,556 - $304,000
-4,588 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$51.97 - $63.0 $238,438 - $289,044
4,588 New
4,588 $276,000
Q1 2020

May 15, 2020

SELL
$28.4 - $50.7 $154,723 - $276,213
-5,448 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.31 - $46.83 $197,816 - $255,129
5,448 New
5,448 $247,000
Q3 2019

Nov 08, 2019

SELL
$35.66 - $44.99 $251,367 - $317,134
-7,049 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$36.57 - $47.97 $102,542 - $134,507
2,804 Added 66.05%
7,049 $307,000
Q1 2019

Apr 29, 2019

BUY
$36.47 - $42.17 $154,815 - $179,011
4,245 New
4,245 $162,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.